← Back to Products
Tirzepatide

Tirzepatide

5mg

Tirzepatide is a next-generation injectable peptide. It is unique because it acts as a dual agonist, activating two different receptors in the body simultaneously. GLP-1 Agonist: Suppresses appetite and slows down stomach emptying, keeping you full for longer. GIP Agonist: Enhances how the body breaks down sugars and fats while reducing inflammation.

Key Benefits

  • Drastic reduction in body fat and overall weight.
  • Control over blood sugar levels and improved insulin sensitivity.
  • Reduction of "food noise" – the constant intrusive thoughts about eating.

Clinical Research

The most common reactions occur at the beginning or when increasing the dose: • Mild nausea or a feeling of being overly full. • Significantly reduced appetite (the intended effect). • Changes in bowel movements (constipation or mild diarrhea). Pro-Tip: Drink plenty of water (at least 2–3 liters per day) and ensure you consume enough protein, even if you do not feel hungry, to preserve muscle mass during weight loss.

Usage & Dosage

Administration & Dosage
  • Dosage and Administration
  • The peptide is administered once a week via subcutaneous injection (in the abdomen or thigh). It is best to take it on the same day each week.
  • Dosage Schedule (Concentration 5mg/1ml)
    • Weeks 1–4: 2.5 mg per week (50 units on the pen) — Adaptation phase.
    • Weeks 5–8: 5.0 mg per week (100 units on the pen) — Therapeutic phase.
    • After Week 8: 5.0 mg or higher (100+ units) as needed, depending on progress and medical advice.
Injection Guide
  1. Practical Instructions for Using the Pen
  2. 1. Setting the Dose: Dial the pen to the required number of units (50 units for the starting dose or 100 units for the full dose).
    • Injection: Clean the skin with alcohol, insert the needle vertically, press the button, and count to 10 before withdrawing the needle.
    • Storage: Keep the pen in the refrigerator (do not freeze). Cold liquid may cause a stinging sensation — take the pen out 15 minutes before use to allow it to reach room temperature.
Dose Reference
10 units = 0.50 mg20 units = 1 mg40 units = 2 mg50 units = 2.5 mg100 units = 5 mg

Possible Side Effects

Tirzepatide may cause side effects in some individuals, particularly during the initial stages of use or when increasing dosage levels.

Potential side effects include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Reduced appetite
  • Mild abdominal discomfort
  • Fatigue
  • Headache

These effects are generally temporary and often improve as the body adapts. Following recommended dosing guidelines may help improve tolerability and reduce unwanted reactions.

Proper Storage

It is recommended that the products are stored at temperatures between 2°C and 8°C in a refrigerator.

Disclaimer

This content is provided for informational purposes only and does not constitute medical advice. The products referenced here are intended strictly for laboratory, scientific, and research use. Always consult a qualified healthcare professional before considering any use or application of these products.